A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
X-linked recessive myotubular myopathy (MTM1) is characterized by severe hypotonia and generalized muscle weakness, with impaired maturation of muscle fibres. We have restricted the candidate region to 280 kb and characterized two candidate genes using positional cloning strategies. The presence of frameshift or missense mutations (of which two are new mutations) in seven patients proved that one of these genes is indeed implicated in MTM1. The protein encoded by the MTM1 gene is highly conserved in yeast, which is surprising for a muscle specific disease. The protein contains the consensus sequence for the active site of tyrosine phosphatases, a wide class of proteins involved in signal transduction. At least three other genes, one located within 100 kb distal from the MTM1 gene, encode proteins with very high sequence similarities and define, together with the MTM1 gene, a new family of putative tyrosine phosphatases in man.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The XLMTM is caused by mutations in the myotubularin 1 (MTM1) gene, located at Xq28.31”
From Current clinical applications of in vivo gene therapy with AAVs (2021) · cites this paper as [31]
In the citing paper
“Furthermore, mounting evidence shows that autophagy is regulated by distinct mechanisms in different cell types [11–26], and these cell type-specific mechanisms underlie the differential vulnerability of separate tissues to autophagy mutations, resulting in heterogenous manifestations of disease.”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [17]
In the citing paper
“For instance, centronuclear myopathy is caused by mutations in the genes encoding MTM1 (myotubularin1) or MTMR14/Jumpy (myotubularin related protein 14) [17,20].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [17]
In the citing paper
“These loss-of-function mutations prevent these enzymes from metabolizing phosphoinositides required for autophagy, thereby disinhibiting autophagy flux and muscle atrophy [17,20].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [17]
Citations
Cites
Basic local alignment search tool
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990) · Journal of Molecular Biology · doi:10.1006/jmbi.1990.9999 · Cited by 98,669
A simple salting out procedure for extracting DNA from human nucleated cells
Miller, S. A., Dykes, D. D., & Polesky, H. F. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.3.1215 · Cited by 20,330
Bronner, C. E., Baker, S. M., Morrison, P. T., Warren, G., Smith, L. G., Lescoe, M. K., Kane, M., Earabino, C., Lipford, J., Lindblom, A., et al. (1994) · Nature · doi:10.1038/368258a0 · Cited by 2,052
2.2 Mb of contiguous nucleotide sequence from chromosome III of C. elegans
Wilson, R., Ainscough, R., Anderson, K., Baynes, C., Berks, M., Bonfield, J., Burton, J., Connell, M., Copsey, T., Cooper, J., et al. (1994) · Nature · doi:10.1038/368032a0 · Cited by 1,465
Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters
Mosser, J., Douar, A.-M., Sarde, C.-O., Kioschis, P., Feil, R., Moser, H., Poustka, A.-M., Mandel, J.-L., & Aubourg, P. (1993) · Nature · doi:10.1038/361726a0 · Cited by 1,202
Self-citationProtein Tyrosine Phosphatases: A Diverse Family of Intracellular and Transmembrane Enzymes
Fischer, E. H., Charbonneau, H., & Tonks, N. K. (1991) · Science · doi:10.1126/science.1650499 · Cited by 956
Locating protein-coding regions in human DNA sequences by a multiple sensor-neural network approach.
Uberbacher, E. C., & Mural, R. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11261 · Cited by 652
Sigma factors from E. coli, B. subtilis, phage SP01, and phage T4 are homologous proteins
Gribskov, M., & Burgess, R. R. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.16.6745 · Cited by 445
Hormones, Growth Factors, and Myogenic Differentiation
Florini, J. R., Ewton, D. Z., & Magri, K. A. (1991) · Annual Review of Physiology · doi:10.1146/annurev.ph.53.030191.001221 · Cited by 423
Exon amplification: a strategy to isolate mammalian genes based on RNA splicing.
Buckler, A. J., Chang, D. D., Graw, S. L., Brook, J. D., Haber, D. A., Sharp, P. A., & Housman, D. E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.4005 · Cited by 420
Research works printed but not linked: 1
- Lanfranchi, G. et al. Identification of 4,370 expressed sequence tags (ESTs) from a 3′-end specific cDNA library of human skeletal muscle by DNA sequencing and fitter hybridization. Genome Res. (in the press).
Cited by
Phosphoinositides in cell regulation and membrane dynamics
Di Paolo, G., & De Camilli, P. (2006) · Nature · doi:10.1038/nature05185 · Cited by 2,790
Protein Tyrosine Phosphatases in the Human Genome
Alonso, A., Sasin, J., Bottini, N., Friedberg, I., Friedberg, I., Osterman, A., Godzik, A., Hunter, T., Dixon, J., & Mustelin, T. (2004) · Cell · doi:10.1016/j.cell.2004.05.018 · Cited by 1,886
Phosphoinositides: Tiny Lipids With Giant Impact on Cell Regulation
Balla, T. (2013) · Physiological Reviews · doi:10.1152/physrev.00028.2012 · Cited by 1,638
“ity phosphotyrosine phosphatase (858), but its lipid phosphatase activity against PtdIns3P (152, 1536, 1814) was later demonstrated both as a GST-fusion protein and in cell expression studies.”
BackgroundSynthesis and Function of 3-Phosphorylated Inositol Lipids
Vanhaesebroeck, B., Leevers, S. J., Ahmadi, K., Timms, J., Katso, R., Driscoll, P. C., Woscholski, R., Parker, P. J., & Waterfield, M. D. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.535 · Cited by 1,535
Nagase, T. (1998) · DNA Research · doi:10.1093/dnares/5.1.31 · Cited by 842
Current clinical applications of in vivo gene therapy with AAVs
Mendell, J. R., Al-Zaidy, S. A., Rodino-Klapac, L. R., Goodspeed, K., Gray, S. J., Kay, C. N., Boye, S. L., Boye, S. E., George, L. A., Salabarria, S., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2020.12.007 · Cited by 743
“The XLMTM is caused by mutations in the myotubularin 1 (MTM1) gene, located at Xq28.”
BackgroundDe Sandre-Giovannoli, A., Chaouch, M., Kozlov, S., Vallat, J.-M., Tazir, M., Kassouri, N., Szepetowski, P., Hammadouche, T., Vandenberghe, A., Stewart, C. L., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/339274 · Cited by 565
“Mutations in MTM1 cause myotubular myopathy (Laporte et al. 1996), a severe muscular disorder, whereas mutations in MTMR2, one of its close homologs, are associated with CMT4B, a demyelinating motor and sensory neuropathy (Bolino et al. 2000).”
BackgroundCombinatorial control of the specificity of protein tyrosine phosphatases
Tonks, N. K., & Neel, B. G. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00196-4 · Cited by 501
Minassian, B. A., Lee, J. R., Herbrick, J.-A., Huizenga, J., Soder, S., Mungall, A. J., Dunham, I., Gardner, R., Fong, C.-Y. G., Carpenter, S., et al. (1998) · Nature Genetics · doi:10.1038/2470 · Cited by 487
“Involvement of PTPs in non-neoplastic disease have been described in only one other human disorder, X-linked myotubular myopath”
BackgroundBolino, A., Muglia, M., Conforti, F. L., LeGuern, E., Salih, M. A. M., Georgiou, D.-M., Christodoulou, K., Hausmanowa-Petrusewicz, I., Mandich, P., Schenone, A., et al. (2000) · Nature Genetics · doi:10.1038/75542 · Cited by 467
PTEN and Myotubularin: Novel Phosphoinositide Phosphatases
Maehama, T., Taylor, G. S., & Dixon, J. E. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.247 · Cited by 461
Nicot, A.-S., Toussaint, A., Tosch, V., Kretz, C., Wallgren-Pettersson, C., Iwarsson, E., Kingston, H., Garnier, J.-M., Biancalana, V., Oldfors, A., et al. (2007) · Nature Genetics · doi:10.1038/ng2086 · Cited by 434
“Patients (1) Sex Mutation Aminoacid change Origin Onset Age (yrs) Central nuclei Pregnancy Ventilation Muscle weakness (2) Facial weakness Ptosis Family 1”
BackgroundSelf-citationFugier, C., Klein, A. F., Hammer, C., Vassilopoulos, S., Ivarsson, Y., Toussaint, A., Tosch, V., Vignaud, A., Ferry, A., Messaddeq, N., et al. (2011) · Nature Medicine · doi:10.1038/nm.2374 · Cited by 335
“CNM's are caused by mutations in the myotubularin ( MTM1 ), dynamin-2 ( DNM2 ) and BIN1 gene”
BackgroundSelf-citationTaylor, G. S., Maehama, T., & Dixon, J. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160255697 · Cited by 338
Centronuclear (myotubular) myopathy
Jungbluth, H., Wallgren-Pettersson, C., & Laporte, J. (2008) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-3-26 · Cited by 321
“These two phospholipids are second messengers with a crucial role in membrane trafficking; by dephosphorylation of PtdIns(3,5)P2, myotubularin also produces PtdIns5P, whose function is not fully characterised [95,115-126].”
Self-citationApproach to the diagnosis of congenital myopathies
North, K. N., Wang, C. H., Clarke, N., Jungbluth, H., Vainzof, M., Dowling, J. J., Amburgey, K., Quijano-Roy, S., Beggs, A. H., Sewry, C., et al. (2014) · Neuromuscular Disorders · doi:10.1016/j.nmd.2013.11.003 · Cited by 330
Structure and function of theprotein tyrosine phosphatases
Fauman, E. B., & Saper, M. A. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)10059-1 · Cited by 340
Wolpowitz, D., Mason, T. B. A., Dietrich, P., Mendelsohn, M., Talmage, D. A., & Role, L. W. (2000) · Neuron · doi:10.1016/s0896-6273(00)80873-9 · Cited by 313
Azzedine, H., Bolino, A., Taïeb, T., Birouk, N., Di Duca, M., Bouhouche, A., Benamou, S., Mrabet, A., Hammadouche, T., Chkili, T., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375034 · Cited by 314
“Mutations of MTM1, a close homologue of MTMR2, lead to myotubular my- opathy (Laporte et al. 1996), a phenotype unrelated to demyelinating CMT.”
BackgroundInfluentialSelf-citationBleyl, S. B., Mumford, B. R., Brown-Harrison, M.-C., Pagotto, L. T., Carey, J. C., Pysher, T. J., Ward, K., & Chin, T. K. (1997) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19971031)72:3<257::aid-ajmg2>3.0.co;2-o · Cited by 314
Synthesis and function of membrane phosphoinositides in budding yeast, Saccharomyces cerevisiae
Strahl, T., & Thorner, J. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.01.015 · Cited by 291
Congenital myopathies: disorders of excitation–contraction coupling and muscle contraction
Jungbluth, H., Treves, S., Zorzato, F., Sarkozy, A., Ochala, J., Sewry, C., Phadke, R., Gautel, M., & Muntoni, F. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.191 · Cited by 280
RYR1 mutations are a common cause of congenital myopathies with central nuclei
Wilmshurst, J. M., Lillis, S., Zhou, H., Pillay, K., Henderson, H., Kress, W., Müller, C. R., Ndondo, A., Cloke, V., Cullup, T., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22119 · Cited by 275
Mammalian phosphoinositide kinases and phosphatases
Sasaki, T., Takasuga, S., Sasaki, J., Kofuji, S., Eguchi, S., Yamazaki, M., & Suzuki, A. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.06.001 · Cited by 283
Blondeau, F., Laporte, J., Bodin, S., Superti-Furga, G., Payrastre, B., & Mandel, J.-L. (2000) · Human Molecular Genetics · doi:10.1093/oxfordjournals.hmg.a018913 · Cited by 270
“The locus responsible for the disease (MTM1) was mapped to proximal Xq28 and the MTM1 gene was identified by positional cloning ( 1 ).”
BackgroundSelf-citationSenderek, J. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg030 · Cited by 274
“Myotubularin (MTM1), the founder member, is mutant in myotubular myopathy (14), while its close homologue MTMR2 is involved in CMT4B1 (11).”
BackgroundCentronuclear myopathies: A widening concept
Romero, N. B. (2010) · Neuromuscular Disorders · doi:10.1016/j.nmd.2010.01.014 · Cited by 260
“Myotubular myopathy is caused by mutations in the MTM1 gene encoding the 30-phosphoinositides phosphatase myotubularin 1 (MTM1) [9].”
BackgroundDowling, J. J., Vreede, A. P., Low, S. E., Gibbs, E. M., Kuwada, J. Y., Bonnemann, C. G., & Feldman, E. L. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000372 · Cited by 236
“Myotubular myopathy is caused by mutations in the myotubularin gene [4].”
BackgroundBuj-Bello, A., Laugel, V., Messaddeq, N., Zahreddine, H., Laporte, J., Pellissier, J.-F., & Mandel, J.-L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212498399 · Cited by 230
Self-citationMyotubularin phosphatases: policing 3-phosphoinositides
Robinson, F. L., & Dixon, J. E. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.06.001 · Cited by 242
MTM1 mutations in X-linked myotubular myopathy
Laporte, J., Biancalana, V., Tanner, S. M., Kress, W., Schneider, V., Wallgren-Pettersson, C., Herger, F., Buj-Bello, A., Blondeau, F., Liechti-Gallati, S., et al. (2000) · Human Mutation · doi:10.1002/(sici)1098-1004(200005)15:5<393::aid-humu1>3.0.co;2-r · Cited by 234
Self-citationAssociation of SET domain and myotubularin-related proteins modulates growth control
Cui, X., Vivo, I. D., Slany, R., Miyamoto, A., Firestein, R., & Cleary, M. L. (1998) · Nature Genetics · doi:10.1038/ng0498-331 · Cited by 238
T-tubule biogenesis and triad formation in skeletal muscle and implication in human diseases
Al-Qusairi, L., & Laporte, J. (2011) · Skeletal Muscle · doi:10.1186/2044-5040-1-26 · Cited by 195
“While myotubularin is ubiquitously expressed, mutations within MTM1 lead to a skeletal muscle disorder: the X-linked form of centronuclear myopathy, also called myotubular myopathy, associating severe muscle atrophy and weakness at birth with abnormal positioning of nuclei [75].”
BackgroundSelf-citationMeins, M., Lehmann, J., Gerresheim, F., Herchenbach, J., Hagedorn, M., Hameister, K., & Epplen, J. T. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.023804 · Cited by 220
Human genetic diseases: a cross-talk between man and yeast
Foury, F. (1997) · Gene · doi:10.1016/s0378-1119(97)00140-6 · Cited by 215
Al-Qusairi, L., Weiss, N., Toussaint, A., Berbey, C., Messaddeq, N., Kretz, C., Sanoudou, D., Beggs, A. H., Allard, B., Mandel, J.-L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900705106 · Cited by 197
Self-citationNovel roles of phosphoinositides in signaling, lipid transport, and disease
Hammond, G. R. V., & Burke, J. E. (2020) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2019.12.007 · Cited by 203
Medical complications in long-term survivors with X-linked myotubular myopathy
Herman, G. E., Finegold, M., Zhao, W., de Gouyon, B., & Metzenberg, A. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70417-8 · Cited by 196
Pyruvate Metabolism inSaccharomyces cerevisiae
PRONK, J. T., YDE STEENSMA, H., & VAN DIJKEN, J. P. (1996) · Yeast · doi:10.1002/(sici)1097-0061(199612)12:16<1607::aid-yea70>3.0.co;2-4 · Cited by 792
Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease
Niemann, A., Berger, P., & Suter, U. (2006) · NeuroMolecular Medicine · doi:10.1385/nmm:8:1-2:217 · Cited by 183
“Mutations in myotubularin cause X-linked myotubular myopathy and mutations in myotubularin-related protein-2 (MTMR2) or MTMR13/SBF2 lead to CMT4B1 or CMT4B2, respectively (Laporte et al., 1996; Bolino et al., 2000; Azzedine et al., 2003; Senderek et al., 2003b).”
Phosphoinositide signaling disorders in human diseases
Pendaries, C., Tronchère, H., Plantavid, M., & Payrastre, B. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00437-x · Cited by 195
Autophagy and ALS: mechanistic insights and therapeutic implications
Chua, J. P., De Calbiac, H., Kabashi, E., & Barmada, S. J. (2022) · Autophagy · doi:10.1080/15548627.2021.1926656 · Cited by 189
“ing MTM1 (myotubularin1) or MTMR14/Jumpy (myotubularin related protein 14) [17,20].”
Laporte, J., Bedez, F., Bolino, A., & Mandel, J.-L. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg273 · Cited by 182
Self-citationPTEN and myotubularin phosphatases: from 3-phosphoinositide dephosphorylation to disease
Wishart, M. J., & Dixon, J. E. (2002) · Trends in Cell Biology · doi:10.1016/s0962-8924(02)02412-1 · Cited by 182
Schaletzky, J., Dove, S. K., Short, B., Lorenzo, O., Clague, M. J., & Barr, F. A. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00132-5 · Cited by 176
Tsujita, K., Itoh, T., Ijuin, T., Yamamoto, A., Shisheva, A., Laporte, J., & Takenawa, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312294200 · Cited by 165
Self-citationChilders, M. K., Joubert, R., Poulard, K., Moal, C., Grange, R. W., Doering, J. A., Lawlor, M. W., Rider, B. E., Jamet, T., Danièle, N., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007523 · Cited by 173
“XLMTM results from loss-of-function mutations in the myotubularin 1 gene (MTM1) (10), which encodes the founder member of a family of 3-phosphoinositide phosphatases acting on the second messengers phosphatidylinositol 3-monophosphate [PI(3)P] and phosphatidylinositol 3,5-bisphosphate [PI(3,5)P2] (11, 12).”
BackgroundCongenital muscle disorders with cores: the ryanodine receptor calcium channel paradigm
TREVES, S., JUNGBLUTH, H., MUNTONI, F., & ZORZATO, F. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.01.005 · Cited by 168
Agrawal, P. B., Pierson, C. R., Joshi, M., Liu, X., Ravenscroft, G., Moghadaszadeh, B., Talabere, T., Viola, M., Swanson, L. C., Haliloğlu, G., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.07.004 · Cited by 167
Increasing Role of Titin Mutations in Neuromuscular Disorders
Savarese, M., Sarparanta, J., Vihola, A., Udd, B., & Hackman, P. (2016) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-160158 · Cited by 166
“Mutations in four different genes have been reported to cause CNM: DNM2 causes an autosomal dominant form [63]; BIN1 and RYR1 mutations may cause autosomal dominant or recessive forms [64, 65]; and the X-linked myotubular myopathy (XLMTM) is due to mutations in the MTM1 gene [66].”
BackgroundProtein Tyrosine Phosphatases: Structure, Function, and Implication in Human Disease
Tautz, L., Critton, D. A., & Grotegut, S. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-562-0_13 · Cited by 157
Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset
Bitoun, M., Bevilacqua, J. A., Prudhon, B., Maugenre, S., Taratuto, A. L., Monges, S., Lubieniecki, F. J., Cancès, C., Uro‐Coste, E., Mayer, M., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21235 · Cited by 164
Genotype–phenotype correlations in X-linked myotubular myopathy
McEntagart, M., Parsons, G., Buj‐Bello, A., Biancalana, V., Fenton, I., Little, M., Krawczak, M., Thomas, N. S. T., Herman, G. E., Clarke, A. J., et al. (2002) · Neuromuscular Disorders · doi:10.1016/s0960-8966(02)00153-0 · Cited by 163
“As yet there is no evidence for heterogeneity in the Xlinked form of this disease and mutations in the MTM1 gene located at Xq28 have been identified in the majority of XMTM cases [4].”
BackgroundReducing dynamin 2 expression rescues X-linked centronuclear myopathy
Cowling, B. S., Chevremont, T., Prokic, I., Kretz, C., Ferry, A., Coirault, C., Koutsopoulos, O., Laugel, V., Romero, N. B., & Laporte, J. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71206 · Cited by 151
“Three main forms of CNM have been characterized: X-linked CNM (XLCNM; OMIM 310400), due to mutations in the phosphoinositides phosphatase myotubularin (MTM1) (3); autosomal recessive CNM (ARCNM,”
Self-citationMyotubularin phosphoinositide phosphatases: cellular functions and disease pathophysiology
Hnia, K., Vaccari, I., Bolino, A., & Laporte, J. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.04.004 · Cited by 162
Self-citationHnia, K., Tronchère, H., Tomczak, K. K., Amoasii, L., Schultz, P., Beggs, A. H., Payrastre, B., Mandel, J. L., & Laporte, J. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44021 · Cited by 146
Self-citationEndosomal Phosphoinositides and Human Diseases
Nicot, A., & Laporte, J. (2008) · Traffic · doi:10.1111/j.1600-0854.2008.00754.x · Cited by 153
“Numerous mutations of the myotubularin (MTM1) gene have been identified in patients affected with X-linked centronuclear myopathy, also called myotubular myopathy (XLCNM, OMIM 310400) (85).”
BackgroundSelf-citationDefects in amphiphysin 2 (BIN1) and triads in several forms of centronuclear myopathies
Toussaint, A., Cowling, B. S., Hnia, K., Mohr, M., Oldfors, A., Schwab, Y., Yiş, U., Maisonobe, T., Stojkovic, T., Wallgren‐Pettersson, C., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0754-2 · Cited by 171
“CNMs have been divided into three forms: the severe X-linked form also called myotubular myopathy is due to mutations in the MTM1 gene encoding the phosphoinositide phosphatase myotubularin (XLMTM, OMIM 310400) [23]; the autosomal dominant C.”
BackgroundSelf-citationKim, S.-A., Vacratsis, P. O., Firestein, R., Cleary, M. L., & Dixon, J. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0431052100 · Cited by 151
Moving and positioning the nucleus in skeletal muscle – one step at a time
Cadot, B., Gache, V., & Gomes, E. R. (2015) · Nucleus · doi:10.1080/19491034.2015.1090073 · Cited by 167
Cao, C., Backer, J. M., Laporte, J., Bedrick, E. J., & Wandinger-Ness, A. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-04-0367 · Cited by 147
“The fact that inactivation of lipid phosphatases results in disease points to the importance of optimal phosphoinositide levels in homeostasis (Laporte et al., 1996; Bo-lino et al., 2000; Bitoun et al., 2005; Niemann et al., 2006; Spinosa et al., 2008).”
InfluentialSelf-citationPelé, M., Tiret, L., Kessler, J.-L., Blot, S., & Panthier, J.-J. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi151 · Cited by 144
“In human, the related X-linked myotubular myopathy has been attributed to truncating or missense mutations in the MTM1 gene encoding myotubularin (8,9,44).”
BackgroundTronchère, H., Laporte, J., Pendaries, C., Chaussade, C., Liaubet, L., Pirola, L., Mandel, J.-L., & Payrastre, B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311071200 · Cited by 145
Self-citationCrystal Structure of a Phosphoinositide Phosphatase, MTMR2
Begley, M. J., Taylor, G. S., Kim, S., Veine, D. M., Dixon, J. E., & Stuckey, J. A. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00486-6 · Cited by 155
Tosch, V., Rohde, H. M., Tronchère, H., Zanoteli, E., Monroy, N., Kretz, C., Dondaine, N., Payrastre, B., Mandel, J.-L., & Laporte, J. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl250 · Cited by 141
“MTM1 is mutated in X-linked myotubular (centronuclear) myopathy (XLMTM) (8), whereas MTMR2 and MTMR13 are mutated in demyelinating Charcot–Marie–Tooth neuropathy types 4B1 and 4B2, respectively (9–11).”
BackgroundInfluentialSelf-citationDoerks, T., Strauss, M., Brendel, M., & Bork, P. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01664-9 · Cited by 164
Böhm, J., Biancalana, V., DeChene, E. T., Bitoun, M., Pierson, C. R., Schaefer, É., Karasoy, H., Dempsey, M. A., Klein, F. A. C., Dondaine, N., et al. (2012) · Human Mutation · doi:10.1002/humu.22067 · Cited by 147
“The X-linked neonatal form (XLMTM; MIM# 310400) is associated with mutations in MTM1 (MIM# 300415), encoding the 3-phosphoinositide phosphatase myotubularin, and involves life-threatening, generalized muscle weakness and respiratory insufficiency [Laporte et al., 1996].”
BackgroundSelf-citationBuj-Bello, A., Fougerousse, F., Schwab, Y., Messaddeq, N., Spehner, D., Pierson, C. R., Durand, M., Kretz, C., Danos, O., Douar, A.-M., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn112 · Cited by 132
“affects one newborn male in 50 000 is caused by mutations in the ubiquitously expressed MTM1 gene that codes for a phosphoinositide phosphatase named myotubularin (2,3).”
BackgroundSelf-citationGanesh, S., Agarwala, K. L., Ueda, K., Akagi, T., Shoda, K., Usui, T., Hashikawa, T., Osada, H., Delgado-Escueta, A. V., & Yamakawa, K. (2000) · Human Molecular Genetics · doi:10.1093/oxfordjournals.hmg.a018916 · Cited by 146
“MTM1 is the founder member of an evolutionarily conserved gene family that includes MTMR2 (17,20).”
BackgroundMuscle-specific alternative splicing of myotubularin-related 1 gene is impaired in DM1 muscle cells
Buj‐Bello, A. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.19.2297 · Cited by 144
Current clinical applications of AAV-mediated gene therapy
Byrne, B. J., Flanigan, K. M., Matesanz, S. E., Finkel, R. S., Waldrop, M. A., D'Ambrosio, E. S., Johnson, N. E., Smith, B. K., Bönnemann, C. G., Carrig, S., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.04.045 · Cited by 163
“132,133 The clinical presentation of XLMTM commonly includes severe hypotonia, skeletal muscle weakness, and ventilatory insufficiency, often presenting shortly after birth.”
Berger, P. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.13.1569 · Cited by 141
Gathering STYX: phosphatase-like form predicts functions for unique protein-interaction domains
Wishart, M. J., & Dixon, J. E. (1998) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01241-9 · Cited by 139
Congenital Myopathies: An Update
Nance, J., Dowling, J. J., Gibbs, E. M., & Bönnemann, C. G. (2012) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-012-0255-x · Cited by 150
“X-linked CNM or myotubular myopathy is caused by a mutation in the MTM1 gene coding for myotubularin, a member of the phosphoinositide phosphatase protein family [67].”
BackgroundNicot, A.-S., Fares, H., Payrastre, B., Chisholm, A. D., Labouesse, M., & Laporte, J. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-12-1120 · Cited by 133
“These two PIs are substrates of myotubularin phosphatases, which are mutated in several neuromuscular disorders (Laporte et al., 1996; Bolino et al., 2000; Azzedine et al., 2003; Laporte et al., 2003; Senderek et al., 2003).”
BackgroundSelf-citationMTM1 mutation associated with X-linked myotubular myopathy in Labrador Retrievers
Beggs, A. H., Böhm, J., Snead, E., Kozlowski, M., Maurer, M., Minor, K., Childers, M. K., Taylor, S. M., Hitte, C., Mickelson, J. R., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003677107 · Cited by 119
“The defective gene, MTM1, was identified in 1996 by positional cloning (3).”
BackgroundSelf-citationKim, S.-A., Taylor, G. S., Torgersen, K. M., & Dixon, J. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111087200 · Cited by 128
Laporte, J. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.9.1505 · Cited by 129
Self-citationPhosphoinositide phosphatases in cell biology and disease
Yang, L., & Bankaitis, V. A. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.12.001 · Cited by 145
“Myotubularin (MTM1), the founding member of the myotubularin family, was discovered by isolation of a gene mutated in X-linked centromyotubular myopathy (Laporte et al., 1996).”
BackgroundBiancalana, V., Caron, O., Gallati, S., Baas, F., Kreß, W., Novelli, G., D’Apice, M. R., Lagier‐Tourenne, C., Buj‐Bello, A., Romero, N. B., et al. (2003) · Human Genetics · doi:10.1007/s00439-002-0869-1 · Cited by 128
“The MTM1 gene that is mutated in myotubular myopathy, is located on Xq28 and was identified in 1996 by positional cloning (Laporte et al. 1996).”
BackgroundSelf-citationRobinson, F. L., & Dixon, J. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505159200 · Cited by 126
Bevilacqua, J. A., Monnier, N., Bitoun, M., Eymard, B., Ferreiro, A., Monges, S., Lubieniecki, F. J., Taratuto, A. L., Laquerrière, A., Claeys, K. G., et al. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01149.x · Cited by 127
The myotubularin family: from genetic disease to phosphoinositide metabolism
Laporte, J., Blondeau, F., Buj-Bello, A., & Mandel, J. L. (2001) · Trends in Genetics · doi:10.1016/s0168-9525(01)02245-4 · Cited by 134
Self-citationJungbluth, H., Zhou, H., Sewry, C. A., Robb, S. A., Treves, S., Bitoun, M., Guicheney, P., Buj‐Bello, A., Bönnemann, C. G., & Muntoni, F. (2007) · Neuromuscular Disorders · doi:10.1016/j.nmd.2007.01.016 · Cited by 127
“CNM is genetically heterogeneous: whilst mutations in the myotubularin (MTM1) gene on chromosome Xq28 are implicated in the X-linked variant (‘‘myotubular myopathy’’) [1,2], mutations in the dynamin 2 (DMN2) gene on chromosome 19p13 have recently been associated with a dominant form [3]; apparently recessive cases rem…”
BackgroundPathogenic Mechanisms in Centronuclear Myopathies
Jungbluth, H., & Gautel, M. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00339 · Cited by 130
Spatio‐temporal analysis of gene expression during aging in Drosophila melanogaster
Seroude, L., Brummel, T., Kapahi, P., & Benzer, S. (2002) · Aging Cell · doi:10.1046/j.1474-9728.2002.00007.x · Cited by 128
Sonnemann, K. J., Fitzsimons, D. P., Patel, J. R., Liu, Y., Schneider, M. F., Moss, R. L., & Ervasti, J. M. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.07.001 · Cited by 141
Analyzing phosphoinositides and their interacting proteins
Rusten, T. E., & Stenmark, H. (2006) · Nature Methods · doi:10.1038/nmeth867 · Cited by 136
Nakagawa, O., Arnold, M., Nakagawa, M., Hamada, H., Shelton, J. M., Kusano, H., Harris, T. M., Childs, G., Campbell, K. P., Richardson, J. A., et al. (2005) · Genes & Development · doi:10.1101/gad.1338705 · Cited by 125
“The only gene shown to be involved in human centronuclear myopathy is myotubularin 1 (MTM1), which encodes a ubiquitously expressed dual-specificity phosphatase ( Laporte et al. 1996, 2003; Buj-Bello et al. 2002).”
BackgroundInfluential“Necklace” fibers, a new histological marker of late-onset MTM1-related centronuclear myopathy
Bevilacqua, J. A., Bitoun, M., Biancalana, V., Oldfors, A., Stoltenburg, G., Claeys, K. G., Lacène, E., Brochier, G., Manéré, L., Laforêt, P., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0472-1 · Cited by 124
“XLMTM is caused by mutations in the MTM1 gene encoding the phosphoinositide phosphatase myotubularin 1 (MTM1) [ 21 ].”
BackgroundCharacterization of the Myotubularin Dual Specificity Phosphatase Gene Family from Yeast to Human
Laporte, J., Blondeau, F., Buj-Bello, A., Tentler, D., Kretz, C., Dahl, N., & Mandel, J.-L. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.11.1703 · Cited by 121
“Results for hMTM1 and hMTMR1 have been previously reported ( 3 ) and are shown here for comparison.”
BackgroundSelf-citationRobb, S. A., Sewry, C. A., Dowling, J. J., Feng, L., Cullup, T., Lillis, S., Abbs, S. J., Lees, M. M., Laporte, J., Manzur, A. Y., et al. (2011) · Neuromuscular Disorders · doi:10.1016/j.nmd.2011.02.012 · Cited by 122
“X-linked myotubular myopathy (XLMTM), caused by mutations in the myotubularin gene (MTM1), causes severe weakness in males, usually of prenatal onset with respiratory failure from birth [1,2].”
Self-citationTodd, E. J., Yau, K. S., Ong, R., Slee, J., McGillivray, G., Barnett, C., Haliloğlu, G., Talim, B., Akçören, Z., Kariminejad, A., et al. (2015) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-015-0364-0 · Cited by 121
“A muscle biopsy taken at 10 weeks of age revealed hypoplastic myofibres, some with internal nuclei, typical features of myotubular myopathy (OMIM 310400) [32].”
BackgroundBerger, P., Schaffitzel, C., Berger, I., Ban, N., & Suter, U. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2132732100 · Cited by 122
Adult-onset autosomal dominant centronuclear myopathy due to BIN1 mutations
Böhm, J., Biancalana, V., Malfatti, E., Dondaine, N., Koch, C., Vasli, N., Kreß, W., Strittmatter, M., Taratuto, A. L., Gonorazky, H. D., et al. (2014) · Brain · doi:10.1093/brain/awu272 · Cited by 124
“Genomic DNA was prepared from peripheral blood by routine procedures and sequenced for all coding exons and intron/exon boundaries of MTM1, DNM2 and BIN1 as described elsewhere (Laporte et al., 1996; Bitoun et al., 2005; Nicot et al., 2007).”
MethodSelf-citationExpanding the clinical, pathological and MRI phenotype of DNM2-related centronuclear myopathy
Susman, R., Quijano-Roy, S., Yang, N., Webster, R., Clarke, N. F., Dowling, J. J., Kennerson, M. L., Nicholson, G. A., Biancalana, V., Ilkovski, B., et al. (2010) · Neuromuscular Disorders · doi:10.1016/j.nmd.2010.02.016 · Cited by 117
“disorders can be based on the mode of inheritance: X-linked CNM/ myotubular myopathy due to mutations in the myotubularin gene (MTM1; Xq28) [1]; autosomal recessive CNM due to mutations in the amphiphysin-2 gene (BIN1; 2q14) [2]; and autosomal dominant CNM caused by mutations in the dynamin-2 gene (DNM2; 19p13.”
BackgroundProtein tyrosine phosphatase variants in human hereditary disorders and disease susceptibilities
Hendriks, W. J. A. J., & Pulido, R. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.05.022 · Cited by 131
Fujita, N., Huang, W., Lin, T.-H., Groulx, J.-F., Jean, S., Nguyen, J., Kuchitsu, Y., Koyama-Honda, I., Mizushima, N., Fukuda, M., et al. (2017) · eLife · doi:10.7554/elife.23367 · Cited by 114
“Mutations in each also are associated with human myopathy and/or cardiomyopathy with T-tubule disorganization (Bashir et al., 1998; Betz et al., 2001; Bitoun et al., 2005; Laporte et al., 1996; Liu et al., 1998; Minetti et al., 1998; Nicot et al., 2007), pointing to the critical importance of membrane-mediated mechani…”
BackgroundRomero, N. B., & Bitoun, M. (2011) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2011.10.006 · Cited by 125
“Three main forms of CNM have been identified according to the mode of inheritance and clinical presentation: (1) the X-linked recessive form, also named myotubular myopathy, presenting as a severe prenatal or neonatal myopathy in the large majority of cases, caused by mutations in the MTM1 gene; (2) the classical auto…”
BackgroundFalcone, S., Roman, W., Hnia, K., Gache, V., Didier, N., Lainé, J., Auradé, F., Marty, I., Nishino, I., Charlet‐Berguerand, N., et al. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201404436 · Cited by 116
“…which exhibits the most severe phenotype and affects newborns, due to mutations in myotubularin ( MTM1 ), a phosphoinositide phosphatase (Laporte et al , 1996), the autosomal dominant form (AD-CNM, OMIM#160150) due to mutations in dynamin 2 ( DNM2 ), a large GTPase (Bitoun et al ,…”
Self-citation
Metadata
- Authors
- Laporte, J., Hu, L. J., Kretz, C., Mandel, J.-L., Kioschis, P., Coy, J. F., Klauck, S. M., Poustka, A., & Dahl, N.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- German Cancer Research Center (DE)
- Uppsala University (SE)
- Venue
- Nature Genetics
- Published
- 1996-06
- Volume
- 13
- Issue
- 2
- Pages
- 175-182
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1984366092
- Cited by
- 639
- References
- 51
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 20 · 2023: 16 · 2022: 19 · 2021: 23 · 2020: 21 · 2019: 26 · 2018: 25 · 2017: 20 · 2016: 21 · 2015: 21 · 2014: 28 · 2013: 35 · 2012: 26
- FWCI
- 6.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- X-linked myotubular myopathy, MTM1 gene, positional cloning, frameshift mutation, missense mutations, yeast homolog, hypotonia, signal transduction, conserved protein families
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Binding Sites, Cloning, Molecular, Genes, Fungal, Humans, Genetic Linkage, Molecular Sequence Data, Muscle Hypotonia, Muscular Diseases, Mutation, Saccharomyces cerevisiae, Tissue Distribution, X Chromosome, Protein Tyrosine Phosphatases, Conserved Sequence, Caenorhabditis elegans, Protein Tyrosine Phosphatases, Non-Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.